19 February 2008
A fatal case of secondary gain; a cautionary tale
Michael D. Freeman, Christopher CentenoAm J Case Rep 2008; 9:97-103 :: ID: 828544
Abstract
Background: The term “secondary gain” is rarely heard outside of a medicolegal context, and is a disparaging term used to describe a patient with a compensable injury in whom symptom exaggeration or fabrication is suspected. The allegation of secondary gain is difficult to confirm, and may arise from a lack of an appropriate diagnostic evaluation and proper attribution of symptoms to pathology. Additionally, clinicians who allege secondary gain or malingering in a patient in the absence of clear evidence may be motivated by economic incentives to make such determinations.
Case Report: We present a tragic case study in which a 32-year-old man with obvious signs of acute posttraumatic cervical myelopathy was subjected to multiple evaluations by more than 10 various clinicians over an 8 month period before he was referred for a cervical spine MRI. Although the patient underwent surgery to decompress the lesion, ultimately he died from an overdose of narcotic pain medication associated with a residual central cord pain syndrome.
Conclusions: There were a variety of systematic or “secondary gain” pressures acting on the clinicians in this case that may have led to the lack of a definitive diagnosis and the resulting improper care. This included a business model that emphasized repeated treatment in the case of the treating chiropractors and the desire for future employment in the case of the physician performing the insurer-mandated evaluation. It is reasonable to examine the motivation of clinicians who allege secondary gain in a patient in a third party evaluation setting.
Keywords: secondary gain, Malingering, cervical myelopathy
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946839
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946674
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947512
Most Viewed Current Articles
21 Jun 2024 : Case report
96,276
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,197
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,128
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,383
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030